Steve Schey

2.5k citations
32 papers · 1.1k · 1 hit paper · h-index 12

Impact in

Papers in

    • Multiple Myeloma Research and Treatments 24
    • Hematopoietic Stem Cell Transplantation 3
    • Acute Myeloid Leukemia Research 1
    • Global Cancer Incidence and Screening 2
    • Cancer survivorship and care 2

Steve Schey

32 papers receiving 1.1k citations

Steve Schey's Hit Papers

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 2019 · 319 citations
3190+2+4Years since publication100200300

Peers

Steve Schey
Comparison fields: 5 of 58
  • Hematology 762
  • Pathology and Forensic Medicine 128
  • Genetics 44
  • Internal Medicine 14
  • Immunology 83
Replace Balkis Meddeb with:
Balkis Meddeb Tunisia
Catarina Geraldes Portugal
Einar Haukås Norway
Bruno Anglaret France
Noémie de Gunzburg France
Biao Xing China
Scott R Marshall United Kingdom
Yıldız Aydın Türkiye
Cesar Rodriguez United States
Xiaodan Luo China
Steve Schey relative to Balkis Meddeb Tunisia Balkis Meddeb's profile →
Citations per field
00.5×2×4×6×7×
Balkis Meddeb · 1×
Citations per year

Countries citing papers authored by Steve Schey

Since Specialization
Citations

This map shows the geographic impact of Steve Schey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Schey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Schey more than expected).

Fields of papers citing papers by Steve Schey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Schey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Schey. The network helps show where Steve Schey may publish in the future.

Co-authors

The 25 scholars most cited alongside Steve Schey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Schey Line = papers co-authored together Steve Schey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2019319
2 2004243
3 2010109
4
The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
200696
5 201056
6 200530
7 201229
8 201728
9 202025
10
Life-threatening motor neurotoxicity in association with bortezomib.
200619
11 201519
12 201818
13 201312
14 201611
15 201610
16 20028
17
An update of the use and outcomes of the new immunomodulatory agent CC-4047 (Actimid) in patients with relapsed/refractory myeloma.
20038
18 20177
19 20106
20 20055

About Steve Schey

Steve Schey is a scholar working on Hematology, Oncology, Economics and Econometrics, Pathology and Forensic Medicine and Rheumatology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Global Cancer Incidence and Screening (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer survivorship and care (2 papers), Galectins and Cancer Biology (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (762 citations), Pathology and Forensic Medicine (128 citations), Genetics (44 citations), Internal Medicine (14 citations) and Immunology (83 citations). Steve Schey has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Matthew J. Streetly, Karen J. Phekoo, Henrik Møller, Mike A. Richards, Lenushka Maharaj, Finbarr E. Cotter, Simon Joel, John G. Gribben, Gordon C Cook and Anthony H. Goldstone. Their work appears in journals such as Blood, British Journal of Haematology, European Journal Of Haematology, American Journal of Hematology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact